Skip to main content

Advertisement

SpringerLink
Log in

Meta-Analysis of Local Invasive Breast Cancer Recurrence After Electron Intraoperative Radiotherapy

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Electron intraoperative radiotherapy (IORT) can be used during breast conserving surgery to treat early-stage invasive breast cancer. Using data from current clinical and observational studies, this study aimed to assess the impact of single-fraction electron IORT on local recurrence rates.

Methods

Studies on single-fraction electron IORT during breast conserving surgery were identified through a search of PubMed and Google Scholar, as well as through secondary referencing. Local recurrence rate was the main outcome of interest. A meta-analysis of proportions using a binomial distribution to model the within-study variability and a random effects model was conducted to estimate a pooled local recurrence rate. To estimate a 5-year recurrence rate, a single-sample Poisson-normal model was applied to model the probability of events occurring during a fixed period (60 months).

Results

The study identified 13 publications. The analysis demonstrated a pooled monthly local recurrence rate of 0.02% per person-month (95% confidence interval CI 0.00–0.06%) for the studies with a follow-up period shorter than 5 years, 0.03% per person-month (95% CI 0.02–0.06%) for studies with a follow-up period of 5 years or longer, and 0.02% per person-month (95% CI 0.01–0.04%) overall. Based on this model, the predicted 5-year local recurrence rate was 2.7% (range 1.9–3.7%).

Conclusions

According to the published literature, the rate of breast cancer local recurrence after electron IORT was 0.02% per person-month, with an adjusted 5-year recurrence rate of 2.7%. These findings support the recent guidelines from the American Society for Radiation Oncology (ASTRO) supporting the use of electron IORT for low-risk patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64:252–71.

    Article  PubMed  Google Scholar 

  2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.

    Article  PubMed  Google Scholar 

  3. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.

    Article  PubMed  Google Scholar 

  4. Litiere S, Werutsky G, Fentiman IS, et al. Breast-conserving therapy versus mastectomy for stage I-II breast cancer: 20-year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13:412–9.

    Article  PubMed  Google Scholar 

  5. Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–16.

    Article  CAS  PubMed  Google Scholar 

  6. Agarwal S, Pappas L, Neumayaer L, Kokeny K, Agarwal J Effects of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer. JAMA Surg. 2014;149:267–74.

    Article  PubMed  Google Scholar 

  7. Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513–20.

    Article  CAS  PubMed  Google Scholar 

  8. Haviland JS, Owen JR, Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of earl breast cancer: 10-year follow-up results of two randomized controlled trials. Lancet Oncol. 2013;14:1086–94.

    Article  PubMed  Google Scholar 

  9. Gage I, Recht A, Gelman R, et al. Long-term outcome following breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1995;33:245–51.

    Article  CAS  PubMed  Google Scholar 

  10. Vaidya JS, Wenz F, Bulsara M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-beast radiotherapy for breast cancer: 5-year results of local control and overall survival from the TARGIT: a randomized trial. Lancet. 2014;383:603–13.

    Article  PubMed  Google Scholar 

  11. Veronesi U, Orecchia R, Maisonneuve P, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomized controlled equivalence trial. Lancet Oncol. 2013;14:1269–77.

    Article  PubMed  Google Scholar 

  12. Manyam B, Tendulkar R, Cherian S, Vicini F, Badiyan SN, Shah C. Evaluating candidacy for hypofractionated radiation therapy, accelerated partial-breast irradiation, and endocrine therapy after breast-conserving surgery: a surveillance epidemiology and end results (SEER) analysis. Am J Clin Oncol. 2016. doi: 10.1097/COC.0000000000000332

    PubMed  Google Scholar 

  13. Vaidya JS, Bulsara M, Wenz F, et al. Reduced mortality with partial-breast irradiation for early breast cancer: a meta-analysis of randomized trials. Int J Radiat Oncol Biol Phys. 2016;96:259–65.

    Article  PubMed  Google Scholar 

  14. Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health Affairs. 2008;27:759–96.

    Article  PubMed  Google Scholar 

  15. Stijnen T, Hamza TH, Ozdemir P. Random-effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat Med. 2010;29:3046–67.

    Article  PubMed  Google Scholar 

  16. Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res. 1995;141:259–77.

    Article  CAS  PubMed  Google Scholar 

  17. Olthof ED, Versleijen MW, Huisman-de Wall G, et al. Taurolidine lock is superior to heparin lock in prevention of catheter related bloodstream infections and occlusions. PLoS ONE. 2014;9:e111216.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Cedolini C, Bertozzi S, Seriau L, et al. Feasibility of conservative breast surgery and intraoperative radiation therapy for early breast cancer: a single-center, open, non-randomized, prospective pilot study. Oncol Rep. 2014;31:1539–46.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Dall’Oglio S, Maluta S, Gabbani M, et al. Intraoperative electron radiotherapy in early-stage breast cancer: a mono-institutional experience. Poster #P4-16-08.

  20. Frasson AL, Zerwes FP, Braga Filho AP, Barbosa FS, Koch HA. Intraoperative radiotherapy in the conventional linear accelerator room for early breast cancer treatment: an alternative choice in developing countries. J Exp Clin Cancer Res. 2007;26:379–84.

    CAS  PubMed  Google Scholar 

  21. Hanna SA, de Barros AC, de Andrade FE, et al. Intraoperative radiation therapy in early breast cancer using linear accelerator outside of the operative suite: an “image-guided” approach. Int J Radiat Oncol Biol Phys. 2014;89:1015–23.

    Article  PubMed  Google Scholar 

  22. Hershko D, Abdah-Bortnyak R, Nevelsky A, Gez E, Fried G, Kuten A. Breast-conserving surgery and intraoperative electron radiotherapy in early breast cancer: experience at the Rambam Health Care Campus. Isr Med Assoc J. 2012;14:550–4.

    PubMed  Google Scholar 

  23. Kawamura M, Itoh Y, Sawaki M, et al. A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 5-year results of local control and cosmetic outcome. Radiat Oncol. 2015;10:150.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Lemanski C, Azria D, Gourgou-Bourgade S, et al. Electrons for intraoperative radiotherapy in selected breast-cancer patients: late results of the Montpellier phase II trial. Radiat Oncol. 2013;8:191.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Mussari S, Sabino Della Sala W, Busana L, et al. Full-dose intraoperative radiotherapy with electrons in breast cancer: first report on late toxicity and cosmetic results from a single-institution experience. Strahlenther Onkol. 2006;182:589–95.

    Article  PubMed  Google Scholar 

  26. Osti MF, Carnevale A, Bracci S, et al. Exclusive electron intraoperative radiotherapy in early-stage breast cancer: a monoinstitutional experience. Anticancer Res. 2013;33:1229–35.

    PubMed  Google Scholar 

  27. Philippson C, Simon S, Vandekerkhove C, et al. Early invasive cancer and partial intraoperative electron radiation therapy of the breast: experience of the Jules Bordet Institute. Int J Breast Cancer. 2014;2014:627352.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Rocco N, Rispoli C, Iannone L, et al. Intraoperative radiation therapy with electrons in breast cancer conservative treatment: our experience. Int J Surg. 2014;12(Suppl 1):S75–8.

    Article  PubMed  Google Scholar 

  29. Wang X, Liu J, Wang W, Feng Q, Wang X. Clinical analysis of intraoperative radiotherapy during conserving surgery of early breast cancer in the Chinese Han population. Oncotarget. 2015;6:43120–6.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Leonardi MC, Maisonneuve P, Mastropasqua MG, et al. How do the ASTRO consensus guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology. Int J Radiat Oncol Biol Phys. 2012;83:806–13.

    Article  PubMed  Google Scholar 

  31. Strnad V, Ott OJ, Hildebrandt G, et al. 5-Year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in situ carcinoma of the female breast: a randomised phase 3, non-inferiority trial. Lancet. 2016;387:229–38.

    Article  PubMed  Google Scholar 

  32. Livi L, Meattini I, Marrazzo L, et al. Accelerated partial-breast irradiation using intensity-modulated radiotherapy versus whole-breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer. 2015;51:451–63.

    Article  PubMed  Google Scholar 

  33. Shah C, Khwaja S, Badiyan S, et al Brachytherapy-based partial breast irradiation is associated with low rates of complications and excellent cosmesis. Brachytherapy. 2013;12:278–84.

    Article  PubMed  Google Scholar 

  34. Niel-Weise BS, Stijnen T, Van den Broek PJ. Anti-infective-treated central venous catheters for total parenteral nutrition or chemotherapy: a systematic review. J Hospital Infect. 2008;69:114–23.

    Article  CAS  Google Scholar 

  35. Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst. 2000;92:269–71.

    Article  CAS  PubMed  Google Scholar 

  36. Stafford D, Szczys R, Becker R, Anderson J, Bushfield S. How breast cancer treatment decisions are made by women in North Dakota. Am J Surg. 1998;176:515–9.

    Article  CAS  PubMed  Google Scholar 

  37. Morrow M, White J, Moughan J, et al: Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol. 2001;19:2254–62.

    Article  CAS  PubMed  Google Scholar 

  38. Shah C, Tendulkar R, Smile T, et al. Adjuvant radiotherapy in early-stage breast cancer: evidence-based options. Ann Surg Oncol. 2016;23:3880–90.

    Article  PubMed  Google Scholar 

  39. Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31:2382–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Shah C, Badiyan S, Khwaja S, et al. Evaluating radiotherapy options in breast cancer: dose intraoperative radiotherapy represents the most cost-efficacious option? Clin Breast Cancer. 2014;14:141–6.

    Article  PubMed  Google Scholar 

  41. Liu FF, Shi W, Done SJ, et al. Identification of a low-risk luminal A breast cancer cohort that may not benefit from breast radiotherapy. J Clin Oncol. 2015;33:2035–40.

    Article  PubMed  Google Scholar 

  42. Correa C, Harris EE, Leonardi MC, et al. Accelerated partial-breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement. Pract Radiat Oncol. 2017;7:73–9.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

This study was funded by IntraOp Medical.

Disclosure

Decision Driver Analytics was a paid consultant to IntraOp Medical, and Jay K. Harness, MD, was a speaker for IntraOp Medical.

Author information

Authors and Affiliations

  1. Center for Cancer Prevention and Treatment, St. Joseph Hospital, 1010 W. La Veta, Suite 675, Orange, CA, 92868, USA

    Jay K. Harness MD, FACS

  2. Decision Driver Analytics/Translational Technologies International, LLC, Asheville, NC, USA

    Kalatu Davies PhD, Christina Via MPH, Elizabeth Brooks PhD & April Zambelli-Weiner PhD

  3. Department of Radiation Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA

    Chirag Shah MD

  4. Michigan Healthcare Professionals, 21st Century Oncology, Farmington Hills, MI, USA

    Frank Vicini MD

Authors
  1. Jay K. Harness MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kalatu Davies PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christina Via MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elizabeth Brooks PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. April Zambelli-Weiner PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chirag Shah MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Frank Vicini MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jay K. Harness MD, FACS.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Harness, J.K., Davies, K., Via, C. et al. Meta-Analysis of Local Invasive Breast Cancer Recurrence After Electron Intraoperative Radiotherapy. Ann Surg Oncol 25, 137–147 (2018). https://doi.org/10.1245/s10434-017-6130-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-017-6130-x

Keywords

Search

Navigation